sch 34343 has been researched along with gentamicin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schneider, K; Shah, PM; Stille, W | 1 |
| Fekety, R; Kurpis, L; Schaberg, D | 1 |
2 other study(ies) available for sch 34343 and gentamicin
| Article | Year |
|---|---|
Bactericidal activity of Sch 34343 alone and in combination with gentamicin.
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Enterobacter; Escherichia coli; Gentamicins; Lactams; Microbial Sensitivity Tests; Staphylococcus aureus | 1985 |
In-vitro activity of Sch 34343 against nosocomial pathogens: methicillin-resistant staphylococci, gentamicin-susceptible and -resistant Streptococcus faecalis, Clostridium difficile and Bacteroides fragilis.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Clostridium; Cross Infection; Enterococcus faecalis; Gentamicins; Humans; Lactams; Methicillin; Penicillin Resistance; Staphylococcus | 1985 |